Recap: Streamline Health Solns Q3 Earnings

Streamline Health Solns (NASDAQ:STRM) reported its Q3 earnings results on Wednesday, December 13, 2023 at 04:35 PM. Here’s…

Streamline Health Solns (NASDAQ:STRM) reported its Q3 earnings results on Wednesday, December 13, 2023 at 04:35 PM.

Here’s what investors need to know about the announcement.

Earnings

Streamline Health Solns beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.

Revenue was down $84 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 6.34% drop in the share price the next day.

Here’s a look at Streamline Health Solns’s past performance:

Quarter Q2 2023 Q1 2023 Q4 2022 Q3 2022
EPS Estimate -0.05 -0.05 0 -0.06
EPS Actual -0.04 -0.05 -0.04 -0.07
Revenue Estimate 5.99M 5.49M 6.63M 5.51M
Revenue Actual 5.77M 5.33M 6.75M 6.22M

To track all earnings releases for Streamline Health Solns visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Aurora Reports 20% YoY Uptick In Global Medical Marijuana, Expects Benefits From International Cannabis Regulatory Reforms

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) announced on Thursday its financial and operational results for the fourth quarter and fiscal year 2024.The company reported a 5% year-over-year increase in revenue to CA$67.4 million ($49.1 million) in the fourth quarter. Global medical cannabis net revenue grew by 20% over the same period to CA$45.6 million. The increase in net revenue1 of $7.7 million was primarily due to higher sales to Australia and Europe in the current period following the success of newly launched innovative cultivars in these markets. 

ACB